Comparison of Two Viscoelastic Testing Devices in a Parturient Population
Authors:
- Daniel GrunebergDGDaniel Gruneberg
- Stefan HoferStefan Hofer
- Herbert SchöchlHSHerbert Schöchl
- Johannes ZipperleJZJohannes Zipperle
- Daniel OberladstätterDaniel Oberladstätter
- Sebastian O. DeckerSDSebastian O. Decker
- Maik Von der ForstMFMaik Von der Forst
- Kevin Michel TourelleKTKevin Michel Tourelle
- Maximilian DietrichMDMaximilian Dietrich
- Markus A. WeigandMWMarkus A. Weigand
- Felix C. F. SchmittFelix C. F. Schmitt
Open Access
- 25 January 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (3) , 692
Abstract
Background: Viscoelastic hemostatic assays (VHAs) have become an integral diagnostic tool in guiding hemostatic therapy, offering new opportunities in personalized hemostatic resuscitation. This study aims to assess the interchangeability of ClotPro® and ROTEM® delta in the unique context of parturient women. Methods: Blood samples from 217 parturient women were collected at three timepoints. A total of 631 data sets were eligible for our final analysis. The clotting times were analyzed via extrinsic and intrinsic assays, and the clot firmness parameters A5, A10, and MCF were analyzed via extrinsic, intrinsic, and fibrin polymerization assays. In parallel, the standard laboratory coagulation statuses were obtained. Device comparison was assessed using regression and Bland–Altman plots. The best cutoff calculations were used to determine the VHA values corresponding to the established standard laboratory cutoffs. Results: The clotting times in the extrinsic and intrinsic assays showed notable differences between the devices, while the extrinsic and intrinsic clot firmness results demonstrated interchangeability. The fibrinogen assays revealed higher values in ClotPro® compared to ROTEM®. An ROC analysis identified VHA parameters with high predictive values for coagulopathy exclusion and yet low specificity. Conclusions: In the obstetric setting, the ROTEM® and ClotPro® parameters demonstrate a significant variability. Device- and indication-specific transfusion algorithms are essential for the accurate interpretation of measurements and adequate hemostatic therapy.Keywords
This publication has 36 references indexed in Scilit:
- Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleedingCochrane Database of Systematic Reviews, 2016
- Goal-directed Hemostatic Resuscitation of Trauma-induced CoagulopathyAnnals of Surgery, 2016
- The place of viscoelastic testing in clinical practiceBritish Journal of Haematology, 2016
- The Effectiveness of Different Functional Fibrinogen Polymerization Assays in Eliminating Platelet Contribution to Clot Strength in ThromboelastometryAnesthesia & Analgesia, 2014
- FIBTEM PLUS Provides an Improved Thromboelastometry Test for Measurement of Fibrin-Based Clot Quality in Cardiac Surgery PatientsAnesthesia & Analgesia, 2013
- Practical application of point-of-care coagulation testing to guide treatment decisions in traumaJournal of Trauma and Acute Care Surgery, 2013
- Point-of-Care TestingAnesthesiology, 2012
- FIBTEM provides early prediction of massive transfusion in traumaCritical Care, 2011
- Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM®)-guided administration of fibrinogen concentrate and prothrombin complex concentrateCritical Care, 2010
- The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of ThrombocytopeniaAnesthesia & Analgesia, 2009